MindWalk Holdings (HYFT) Gross Profit (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Gross Profit of $1820.1 for Q2 2026, down 100.0% year-over-year from $3.1 billion in Q2 2025, and down 99.9% quarter-over-quarter from $1.8 million in Q1 2026.
MindWalk Holdings (HYFT) Gross Profit (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Gross Profit for 7 consecutive years, with $1820.1 the latest figure, recorded in Q2 2026.
- In Q2 2026, Gross Profit fell 100.0% year-over-year to $1820.1; the TTM figure through Apr 2026 stood at $1.9 billion (down 50.39% YoY), while the FY2026 annual figure was $6.7 million, up 62.21% from the prior year.
- Gross Profit eased to $1820.1 in Q2 2026 per HYFT's latest filing, from $1.8 million in the prior quarter.
- Across five years, Gross Profit topped out at $3.1 billion in Q2 2025 and bottomed at -$3.6 million in Q2 2024.
- Historically, Gross Profit has averaged $322.8 million across 5 years, with a median of $2.1 million in 2023.
- Annual changes were most pronounced in 2022 — Gross Profit soared 118696394.12% — and 2024, when it sank 244.96%.
- MindWalk Holdings' Gross Profit stood at $2.1 million in 2022, then sank by 99.9% to $2178.6 in 2023, then soared by 45916.85% to $1.0 million in 2024, then surged by 191318.82% to $1.9 billion in 2025, then plunged by 100.0% to $1820.1 in 2026.
- Business Quant data shows HYFT's Gross Profit at $1820.1 in Q2 2026, $1.8 million in Q1 2026, and $1.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1,820.12 |
| Apr 30, 2026 | 1,820.12 |
| Jan 31, 2026 | 1.78 Mn |
| Jan 31, 2026 | 1.78 Mn |
| Oct 31, 2025 | 1.92 Bn |
| Oct 31, 2025 | 1.92 Bn |
| Jul 31, 2025 | 1.11 Mn |
| Jul 31, 2025 | 1.11 Mn |
| Apr 30, 2025 | 3.13 Bn |
| Apr 30, 2025 | 3.13 Bn |
| Jan 31, 2025 | 1.24 Mn |
| Jan 31, 2025 | 1.24 Mn |
| Oct 31, 2024 | 1.00 Mn |
| Oct 31, 2024 | 1.00 Mn |
| Jul 31, 2024 | 737.62 Mn |
| Jul 31, 2024 | 737.62 Mn |
| Apr 30, 2024 | -3.58 Mn |
| Apr 30, 2024 | -3.58 Mn |
| Jan 31, 2024 | 2.36 Mn |
| Jan 31, 2024 | 2.36 Mn |